Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:5:130-5.
doi: 10.2174/1874192401105010130. Epub 2011 Jun 15.

Pharmacokinetic considerations for digoxin in older people

Geoffrey M Currie  1 , Janelle M Wheat, Hosen Kiat
Affiliations

Pharmacokinetic considerations for digoxin in older people

Geoffrey M Currie et al. Open Cardiovasc Med J. 2011.

Abstract

Objective: This review aims to arm readers with a deep understanding of pharmacokinetics of digoxin.

Data sources: Pharmacology and pharmacokinetic references texts, and peer reviewed medical journal manuscripts indexed on Medline included based on currency, accuracy and appropriateness.

Results: Physiologic changes and disease associated with aging have an impact on pharmacokinetics and pharmacodynamics of medications. Altered drug response and increased adverse reactions are common amongst the elderly. The narrow therapeutic index of digoxin and pharmacokinetic changes associated with aging increases the risk of toxicity. In the aging population, a number of factors combine to increase the risk, severity and likelihood of hospitalisation or death due to adverse drug effects: changes to absorption, distribution, metabolism and excretion,increased susceptibility to drug sensitivity,co-existing pathology,polypharmacy.

Conclusion: A thorough understanding of digoxin pharmacokinetics in the older person is essential for improved therapeutic outcomes, improved compliance, reduced morbidity and improved quality of life.

Keywords: Ageing; digoxin; pharmacokinetics; toxicity..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
The two compartment model for digoxin.
Fig. (2)
Fig. (2)
The two compartment model for digoxin in the elderly.
See this image and copyright information in PMC

References

    1. Jambhekar SS, Breen PJ. Basic pharmacokinetics. London: Pharmaceutical Press; 2009.
    1. Shargel L, Wu-Pong S, Yu ABC. Applied biopharmaceutics and pharmacokinetics. 5th. New York: McGraw Hill; 2005.
    1. Ritschel WA, Kearns GL. Handbook of basic pharmacokinetcis including clinical applications. 6th. Washington: American Pharmacists Association; 2004.
    1. Winter ME. Basic clinical pharmacokinetics. 4th. Philadelphia: Lippincott Williams Wilkins; 2004.
    1. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother. 2004;2:274–302. - PubMed

LinkOut - more resources